Human Genome Epidemiology Literature Finder
Records 1 - 19 (of 19 Records) |
Query Trace: Neoplasms and IGFBP1[original query] |
---|
Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006 Oct 15 (10): 1993-7. Cheng Iona, Penney Kathryn L, Stram Daniel O, Le Marchand Loic, Giorgi Elena, Haiman Christopher A, Kolonel Laurence N, Pike Malcolm, Hirschhorn Joel, Henderson Brian E, Freedman Matthew |
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. British journal of cancer 2006 Jan 94 (2): 299-307. Canzian F, McKay J D, Cleveland R J, Dossus L, Biessy C, Rinaldi S, Landi S, Boillot C, Monnier S, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann P H, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita H B, van Gils C H, Peeters P H M, Pera G, Ardanaz E, Chirlaque M-D, Quirós J R, Larrañaga N, Martínez-García C, Allen N E, Key T J, Bingham S A, Khaw K-T, Slimani N, Norat T, Riboli E, Kaaks |
Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population. The Journal of clinical endocrinology and metabolism 2007 Sep 92 (9): 3660-6. Cheng Iona, DeLellis Henderson Katherine, Haiman Christopher A, Kolonel Laurence N, Henderson Brian E, Freedman Matthew L, Le Marchand Lo |
Association of gastric cancer with tyrosine hydroxylase gene polymorphism in a northwestern Chinese population. Clinical and experimental medicine 2007 Sep 7 (3): 98-101. Li Z Q, Yu W P, Xie X D, Li P Q, Guo T K, Zhang W H, An L Z, Wang X |
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PloS one 2008 3 (7): e2578. Patel Alpa V, Cheng Iona, Canzian Federico, Le Marchand Loïc, Thun Michael J, Berg Christine D, Buring Julie, Calle Eugenia E, Chanock Stephen, Clavel-Chapelon Francoise, Cox David G, Dorronsoro Miren, Dossus Laure, Haiman Christopher A, Hankinson Susan E, Henderson Brian E, Hoover Robert, Hunter David J, Kaaks Rudolf, Kolonel Laurence N, Kraft Peter, Linseisen Jakob, Lund Eiliv, Manjer Jonas, McCarty Catherine, Peeters Petra H M, Pike Malcolm C, Pollak Michael, Riboli Elio, Stram Daniel O, Tjonneland Anne, Travis Ruth C, Trichopoulos Dimitrios, Tumino Rosario, Yeager Meredith, Ziegler Regina G, Feigelson Heather Spencer, |
Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival. The Prostate 2009 Sep 69 (12): 1281-91. Johansson Mattias, McKay James D, Rinaldi Sabina, Wiklund Fredrik, Adami Hans-Olov, Grönberg Henrik, Kaaks Rudolf, Stattin P |
Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk. Carcinogenesis 2009 Dec 30 (12): 2042-6. Terry Kathryn L, Tworoger Shelley S, Gates Margaret A, Cramer Daniel W, Hankinson Susan |
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast cancer research : BCR 2009 11 (5): R76. Neuhausen Susan L, Brummel Sean, Ding Yuan Chun, Singer Christian F, Pfeiler Georg, Lynch Henry T, Nathanson Katherine L, Rebbeck Timothy R, Garber Judy E, Couch Fergus, Weitzel Jeffrey, Narod Steven A, Ganz Patricia A, Daly Mary B, Godwin Andrew K, Isaacs Claudine, Olopade Olufunmilayo I, Tomlinson Gail, Rubinstein Wendy S, Tung Nadine, Blum Joanne L, Gillen Daniel |
A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Human molecular genetics 2010 Aug 19 (15): 3089-101. Schumacher Fredrick R, Cheng Iona, Freedman Matthew L, Mucci Lorelei, Allen Naomi E, Pollak Michael N, Hayes Richard B, Stram Daniel O, Canzian Federico, Henderson Brian E, Hunter David J, Virtamo Jarmo, Manjer Jonas, Gaziano J Michael, Kolonel Laurence N, Tjønneland Anne, Albanes Demetrius, Calle Eugenia E, Giovannucci Edward, Crawford E David, Haiman Christopher A, Kraft Peter, Willett Walter C, Thun Michael J, Le Marchand Loïc, Kaaks Rudolf, Feigelson Heather Spencer, Bueno-de-Mesquita H Bas, Palli Domenico, Riboli Elio, Lund Eiliv, Amiano Pilar, Andriole Gerald, Dunning Alison M, Trichopoulos Dimitrios, Stampfer Meir J, Key Timothy J, Ma Ji |
Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density. Breast cancer research and treatment 2010 Oct 123 (3): 843-55. Taverne Cornelia W, Verheus Martijn, McKay James D, Kaaks Rudolf, Canzian Federico, Grobbee Diederick E, Peeters Petra H M, van Gils Carla |
IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families. Breast cancer research and treatment 2011 Jun 127 (3): 785-94. Rosendahl Ann H, Hietala Maria, Henningson Maria, Olsson Håkan, Jernström Hele |
Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk. Gynecologic oncology 2011 Feb 120 (2): 174-8. McGrath Monica, Lee I-Min, Buring Julie, De Vivo Immacula |
Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. Cancer epidemiology 2012 Apr 36 (2): 206-11. Dong Xiaoqun, Li Yanan, Tang Hongwei, Chang Ping, Hess Kenneth R, Abbruzzese James L, Li Dongh |
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Human molecular genetics 2011 Jun 20 (11): 2263-72. Pearce Celeste Leigh, Doherty Jennifer A, Van Den Berg David J, Moysich Kirsten, Hsu Chris, Cushing-Haugen Kara L, Conti David V, Ramus Susan J, Gentry-Maharaj Aleksandra, Menon Usha, Gayther Simon A, Pharoah Paul D P, Song Honglin, Kjaer Susanne K, Hogdall Estrid, Hogdall Claus, Whittemore Alice S, McGuire Valerie, Sieh Weiva, Gronwald Jacek, Medrek Krzysztof, Jakubowska Anna, Lubinski Jan, Chenevix-Trench Georgia, , Beesley Jonathan, Webb Penelope M, Berchuck Andrew, Schildkraut Joellen M, Iversen Edwin S, Moorman Patricia G, Edlund Christopher K, Stram Daniel O, Pike Malcolm C, Ness Roberta B, Rossing Mary Anne, Wu Anna |
Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55. PloS one 2013 8 (6): e65313. Ozhand Ali, Lee Eunjung, Wu Anna H, Ellingjord-Dale Merete, Akslen Lars A, McKean-Cowdin Roberta, Ursin Gis |
Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels. International journal of cancer 2016 May . Bonilla Carolina, Lewis Sarah J, Rowlands Mari-Anne, Gaunt Tom R, Smith George Davey, Gunnell David, Palmer Tom, Donovan Jenny L, Hamdy Freddie C, Neal David E, Eeles Rosalind, Easton Doug, Kote-Jarai Zsofia, Olama Ali Amin Al, Benlloch Sara, Muir Kenneth, Giles Graham G, Wiklund Fredrik, Gronberg Henrik, Haiman Christopher A, Schleutker Johanna, Nordestgaard Børge G, Travis Ruth C, Pashayan Nora, Khaw Kay-Tee, Stanford Janet L, Blot William J, Thibodeau Stephen, Maier Christiane, Kibel Adam S, Cybulski Cezary, Cannon-Albright Lisa, Brenner Hermann, Park Jong, Kaneva Radka, Batra Jyotsna, Teixeira Manuel R, Pandha Hardev, , Lathrop Mark, Martin Richard M, Holly Jeff M |
Identification of clinical prognostic features of esophageal cancer based on m6A regulators. Frontiers in immunology 2022 9 13 950365. Wang Huimei, Zhang Yiping, Chen Lin, Liu Yufeng, Xu Chen, Jiang Dongxian, Song Qi, Wang Haixing, Wang Liyan, Lin Yu, Chen Yuanmei, Chen Junqiang, Xu Yuanji, Hou Yingyo |
A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma. International journal of cancer 2022 6 151 (9): 1565-1577. Jo Jung Hyun, Jung Dawoon E, Lee Hee Seung, Park Soo Been, Chung Moon Jae, Park Jeong Youp, Bang Seungmin, Park Seung Woo, Cho Sangsook, Song Si You |
Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer. Frontiers in genetics 2022 12 13 1026871. Wu Xin, Wang Qiong, Liu Peifa, Sun Linde, Wang |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: